Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Aug 15, 2024 12:54am
164 Views
Post# 36179925

RE:RE:RE:TODAY’S NUMBERS

RE:RE:RE:TODAY’S NUMBERSHey Spammeeeee.  All the posters here that own shares are delighted with the rise in the share price.  Doubling your money is never easy to do.  In case you didn't read it Carlyle Group has entered into a deal to buy Vantive who is the defacto licensee of Spectral's PMX and EAA.  Spectral has reached 126 of 150 in the Tigris trial with completion estimated to be at the end of 2024 and Spectral has enough funds to finish the trial with no further raises needed.  Although you credit posters here as the main reason for the share price rise perhaps you should also consider the above facts.  You might see that share prices rise on factual and material developments.  If you'd like to join the happy club buy a few shares.  There's lots more good news pending that will take the share price much higher.  As Rev says don't wait too long as these levels won't last forever.  Or just remain a basher with several of your collegues here....


<< Previous
Bullboard Posts
Next >>